Edition:
United Kingdom

People: Boston Scientific Corp (BSX.N)

BSX.N on New York Stock Exchange

42.55USD
21 Aug 2019
Change (% chg)

$0.05 (+0.12%)
Prev Close
$42.50
Open
$42.78
Day's High
$42.86
Day's Low
$42.32
Volume
1,084,041
Avg. Vol
1,861,377
52-wk High
$43.65
52-wk Low
$31.57

Mahoney, Michael 

Mr. Michael F. Mahoney is Chairman of the Board, President, Chief Executive Officer of the Company. He joined the Company as our President in October 2011, and became our President and Chief Executive Officer and a director in November 2012. Mr. Mahoney became our Chairman of the Board in May 2016. Prior to joining the Company, he was Worldwide Chairman of the Medical Devices and Diagnostics division of Johnson & Johnson from January 2011 to September 2011, overseeing 50,000 employees and seven franchises. Prior to assuming this position, Mr. Mahoney served as Worldwide Group Chairman of Johnson & Johnson's DePuy franchise, an orthopedics and neurosciences business, from April 2007 through January 2011. From January 2001 through March 2007, Mr. Mahoney served as President and Chief Executive Officer of Global Healthcare Exchange, a provider of supply chain solutions and services that brings together hospitals, manufacturers, distributors and group purchasing organizations. Mr. Mahoney began his career at General Electric Medical Systems, where he spent 12 years, culminating in the role of General Manager of the Healthcare Information Technology business.

Basic Compensation

Total Annual Compensation, USD 3,363,400
Restricted Stock Award, USD 7,643,880
Long-Term Incentive Plans, USD --
All Other, USD 2,963,620
Fiscal Year Total, USD 13,970,900

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Michael Mahoney

13,970,900

Daniel Brennan

3,665,820

Kevin Ballinger

2,841,490

Joseph Fitzgerald

4,036,320

Edward Mackey

3,818,020

Ian Meredith

--
As Of  31 Dec 2018